Startup aims to give castoff Vertex drug new life as Alzheimer’s treatment
May 16, 2018 at 07:00 AM EDT
Cambridge-based EIP Pharma, which licensed the drug from Vertex in 2014, said Wednesday that it had raised $20.5 million to help fund a large, mid-stage trial.
